Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of All Sterile Compounded Drugs Due to a Potential Lack of Sterility Assurance FDA BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York CJC 1295 Ipamorelin Blend 5MG Research Peptide Combination